The Anesthesia and
Respiratory Therapy Market
This report is focused on the anesthesia and respiratory therapy markets, which involve equipment to help diagnose and treat cardiopulmonary disorders, including asthma, COPD, cystic fibrosis, emphysema, immature infant lungs, pleural effusion, pneumonia, tuberculosis, and most recently COVID-19. More than one billion people suffer from either acute or chronic respiratory conditions with four million people dying prematurely from one or more of the conditions every year. Also included in this report is sleep therapy, which is a closely related field to respiratory therapy. Specific devices included are anesthesia machines and workstations, nitrous oxide systems, capnography, ventilators, oxygen concentrators, CPAP, and sleep diagnostic devices.Â
This report covers a global anesthesia and respiratory therapy market, and in addition to details on specific equipment types includes associated accessories, consumables, and services. This report also features regional analysis as well as country-level analysis for key markets.
THE PROBLEM
The respiratory therapy market was positively impacted by the pandemic due to the rapid increase of critically ill patients. However, as most of this demand has been met, identifying new opportunities can be a challenge—particularly without up-to-date information on contracts, contract winners, discounts and prices, and forecasted tenders in the global healthcare markets.
SOLUTION AND BENEFITS
Vamstar has brought together a team of seasoned software developers, machine learning engineers, market access and procurement experts, and medical device market analysts, all committed to a common vision: creating the trusted source of buyer, supplier, contract data, and market analysis in healthcare.
Drive strategy with regularly updated datasets.
Identify which product markets hold the most opportunity.
Gain insight into competitive positioning.
Visualize the comprehensive global market or drill down into product-level detail.
Contact
